iShares iBonds Dec 2032 Term Corporate ETF (IBDX) Short Interest Ratio & Short Volume

Short interest is the volume of iShares iBonds Dec 2032 Term Corporate ETF shares that have been sold short but have not yet been closed out or covered. As of May 15th, investors have sold 75,700 shares of IBDX short. Learn More on iShares iBonds Dec 2032 Term Corporate ETF's current short interest.

iShares iBonds Dec 2032 Term Corporate ETF saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 75,700 shares, an increase of 39.7% from the previous total of 54,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to iShares iBonds Dec 2032 Term Corporate ETF: Avantis Core Fixed Income ETF (0.05%), First Trust Core Investment Grade ETF (0.37%), SPDR Portfolio Long Term Corporate Bond ETF (2.41%), iShares ESG Aware USD Corporate Bond ETF (0.05%), VanEck CLO ETF (0.61%), Vanguard Total Corporate Bond ETF (0.36%), Invesco Variable Rate Investment Grade ETF (0.26%), iShares ESG Aware 1-5 Year USD Corporate Bond ETF (0.11%), Invesco BulletShares 2031 Corporate Bond ETF (0.08%), JPMorgan BetaBuilders U.S. Aggregate Bond ETF (0.16%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling IBDX is an investing strategy that aims to generate trading profit from iShares iBonds Dec 2032 Term Corporate ETF as its price is falling. IBDX shares are trading down $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for iShares iBonds Dec 2032 Term Corporate ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IBDX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IBDX, twice per month. The most recent reporting period available is May, 15 2025.